Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploration oxidative stress underlying gastroesophageal reflux disease and therapeutic targets identification: a multi-omics Mendelian randomization study. | Postgrad Med J | 2025 | 39671389 | PubTator, text mining | PubMed |
| Investigation and validation of neurotransmitter receptor-related biomarkers for forecasting clinical outcomes and immunotherapeutic efficacy in breast cancer. | Gene | 2025 | 39615806 | PubTator, text mining | PubMed |
| Water-Soluble Lynx1 Upregulates Dendritic Spine Density and Stimulates Astrocytic Network and Signaling. | Mol Neurobiol | 2025 | 39565568 | PubTator, text mining | PubMed |
| Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery. | HPB (Oxford) | 2025 | 39562183 | PubTator, text mining | PubMed |
| PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. | Nat Commun | 2024 | 39737899 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer. | BMC Urol | 2024 | 39707285 | PubTator, text mining | PubMed |
| Nanocavities for Molecular Optomechanics: Their Fundamental Description and Applications. | ACS Photonics | 2024 | 39584033 | PubTator, text mining | PubMed |
| Application of large-scale and multicohort plasma proteomics data to discover novel causal proteins in gastric cancer. | Discov Oncol | 2024 | 39422802 | PubTator, text mining | PubMed |
| Genetic Markers of Susceptibility in Gastric Cancer: A Comprehensive Systematic Review. | Cureus | 2024 | 39355481 | PubTator, text mining | PubMed |
| Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies. | Cancers (Basel) | 2024 | 39272956 | PubTator, text mining | PubMed |
| Human intermediate prostate cancer stem cells contribute to the initiation and development of prostate adenocarcinoma. | Stem Cell Res Ther | 2024 | 39256886 | PubTator, text mining | PubMed |
| A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer. | PeerJ | 2024 | 39119106 | PubTator, text mining | PubMed |
| Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer. | MAbs | 2024 | 39113562 | PubTator, text mining | PubMed |
| Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells. | Mol Ther Oncol | 2024 | 38939825 | PubTator, text mining | PubMed |
| Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk. | Int J Cancer | 2024 | 38924078 | PubTator, text mining | PubMed |
| Pan-cancer analysis of PSCA that is associated with immune infiltration and affects patient prognosis. | PLoS One | 2024 | 38917176 | PubTator, text mining | PubMed |
| Single-cell analysis uncovers high-proliferative tumour cell subtypes and their interactions in the microenvironment of gastric cancer. | J Cell Mol Med | 2024 | 38894657 | PubTator, text mining | PubMed |
| T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer. | Cancer Biol Ther | 2024 | 38801069 | PubTator, text mining | PubMed |
| The effects of inhaled corticosteroids on healthy airways. | Allergy | 2024 | 38686450 | PubTator, text mining | PubMed |
| Significance of PSCA as a novel prognostic marker and therapeutic target for cancer. | Cancer Cell Int | 2024 | 38627732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=4